MLchartDataset catalogue

HER-2/neu peptide vaccine

Term · Oncology and biomedicine · MLC-T-ONC-014100

A cancer vaccine comprised of peptides derived from the extracellular domain of the tumor-associated antigen Her-2/neu with potential antineoplastic activity. HER-2/neu peptide vaccine may induce antibodies with anti-tumor activity and may also elicit a specific CD8 T-cell response against specific tumor cell types.

Table 1. Record
IdentifierMLC-T-ONC-014100
FieldOncology and biomedicine
AbbreviationHER-2
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-014100",
  "term": "HER-2/neu peptide vaccine",
  "field": "Oncology and biomedicine",
  "definition": "A cancer vaccine comprised of peptides derived from the extracellular domain of the tumor-associated antigen Her-2/neu with potential antineoplastic activity. HER-2/neu peptide vaccine may induce antibodies with anti-tumor activity and may also elicit a specific CD8 T-cell response against specific tumor cell types.",
  "abbreviation": "HER-2",
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/her-2-neu-peptide-vaccine/"
}

Record 8,420 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.